Skip to content

Application of Different Modes of Esketamine Administration in Pediatric Day Circumcision

Application of Different Modes of Esketamine Administration in Pediatric Day Circumcision

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05811221
Enrollment
70
Registered
2023-04-13
Start date
2023-04-02
Completion date
2023-06-01
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pediatric circumcision, Mode of administration, Day surgery, Esketamine

Brief summary

To explore the application of different administration modes of esketamine in pediatric day circumcision, in order to find an anesthesia scheme more suitable for day pediatric circumcision.

Detailed description

The current clinical study believes that esketamine is suitable for pediatric anesthesia because of its advantages of light respiratory depression, low secretions, low incidence of psychomotor reactions and fast recovery of anesthesia, but there are few related studies on its administration mode and timing in clinical application, this study aims to explore the application of different administration methods of esketamine in pediatric day circumcision, and find an anesthesia scheme more suitable for day circumcision, in order to provide new ideas for anesthesia for pediatric day circumcision.

Interventions

DRUGEsketamine of single injection

Single group: give esketamine 0.75 mg/kg at the time of induction

DRUGEsketamine of Intermittent injection

Intermittent group: give esketamine 0.5mg/kg during anesthesia induction, and during the measuring ring esketamine 0.25mg/kg was given again

Sponsors

Yangzhou University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) class I and II children * Age 5-12 years * Foreskin cerclage is proposed * No history of upper respiratory tract infection in the past two weeks * Obtain the consent of the child's family

Exclusion criteria

* Hepatic and renal insufficiency, coagulation dysfunction * Those who are allergic to esketamine * History of cognitive impairment * epilepsy * other psychiatric and neurological disorders

Design outcomes

Primary

MeasureTime frameDescription
One-time success rate of anesthesiaDuring surgeryNo movement during anesthesia

Secondary

MeasureTime frameDescription
Diastolic blood pressureDuring surgeryDiastolic blood pressure
Heart rateDuring surgeryHeart rate
intraoperative propofol dosage, esketamine dosageDuring surgeryintraoperative propofol dosage, esketamine dosage
Duration of surgeryDuring surgeryDuration of surgery
Systolic blood pressureDuring surgerySystolic blood pressure
Time to talkDuring surgeryTime to talk
VAS(visual analogue scale) score12 hours after the end of surgeryA score to assess pain, use a swimming ruler about 10 cm long, marked with 10 scales on one side, with 0 and 10 ends at each end, 0 points means no pain, and 10 points represent the most severe pain that is unbearable.
Incidence of adverse effects (hypotension, hypertension, respiratory depression, postoperative pain, diplopia, mania)12 hours after the end of surgeryIncidence of adverse effects (hypotension, hypertension, respiratory depression, postoperative pain, diplopia, mania)
Time to open eyesDuring surgeryTime to open eyes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026